WHR
59
-2
EOG
30
-2
FAST
42
-2
D
37
2
PSX
29
2
M
55
7
KIM
58
-2
LRCX
61
2
MPC
33
2
GOOG
81
-2
GM
63
2
MNST
59
7
XRAY
34
3
WYNN
36
2
BWA
45
3
WMT
70
2
LYB
43
6
DNB
58
2
PRU
50
3
FDX
40
4
WHR
59
-2
EOG
30
-2
FAST
42
-2
D
37
2
PSX
29
2
M
55
7
KIM
58
-2
LRCX
61
2
MPC
33
2
GOOG
81
-2
GM
63
2
MNST
59
7
XRAY
34
3
WYNN
36
2
BWA
45
3
WMT
70
2
LYB
43
6
DNB
58
2
PRU
50
3
FDX
40
4
Financhill
Back

iShares MSCI New Zealand ETF Vs. Aligos Therapeutics Industry Stock Comparison

Sell
49

ENZL
iShares MSCI New Zealand ETF

Last Price:
$45.97
Seasonality Move:
1.09%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.32
Seasonality Move:
-16.03%
Sell
49
iShares MSCI New Zealand ETF (ENZL) is a Sell

Is iShares MSCI New Zealand ETF a Buy, Sell or Hold?

  • The current iShares MSCI New Zealand ETF [ENZL] share price is $45.50. The Score for ENZL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • ENZL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ENZL Stock Price Chart

What is iShares MSCI New Zealand ETF's stock price today?

  • The iShares MSCI New Zealand ETF share price today is $45.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENZL is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ENZL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 42.54 Sell
Chaikin Money Flow: -580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.51 - 48.13) Sell
Bollinger Bands (100): (46.65 - 49.35) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

ENZL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.36 Buy
20-day SMA: 46.61 Sell
50-day SMA: 47.36 Sell
200-day SMA: 46.74 Sell
8-day EMA: 45.48 Buy
20-day EMA: 46.2 Sell
50-day EMA: 47.07 Sell
200-day EMA: 47.11 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

iShares MSCI New Zealand ETF Earnings Growth & ENZL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

iShares MSCI New Zealand ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):